The mechanism underlying the positive association between the sCD36 and T2DM is not clearly defined, but current reports implicate that CD36 contributes to the development of T2DM on two levels: insulin resistance [5,7,8,10] and pancreatic β-cell dysfunction and damage [11,12]. The gene discussed is CD36; the disease is Insulin resistance.